Addtech Ab, a Nordic technology trading group, acquired the Finnish company Leica Nilomark Oy. Leica will become a part of Immuno Diagnostics Oy, a Finnish subsidiary of Addtech Life Science business unit. The well functioning logistics and international connections in Greater Helsinki set a good basis for the group’s growth in Finland.
Leica Nilomark Oy imports, markets and sells instruments and programs for health industry and medical research laboratories. The company has a strong market position in Finland, and it represents the leading suppliers of its field.
– The products and expertise of Leica Nilomark Oy complement well the business of Immuno Diagnostics. The acquisition is part of Addtech group’s strategy to grow in chosen markets, and it opens up new opportunities for Addtech Life Science. At the same time, it offers Leica Nilomark continuity and possibilities for developing their business, says Mr. Artur Aira, CEO at the Addtech Life Science business unit.
Addtech aims to grow particularly in the Nordic market. At the moment, the group owns more than 120 companies, and about 20 of them are located in Finland. The Helsinki region is an attractive target for investment for Addtech, since the economic stability, market potential and infrastructure of the area meet the group’s requirements. The potential companies to be acquired as well as Addtech’s own warehouses are concentrated in the Helsinki area.
– Greater Helsinki has a lot of highly skilled workers in our areas of expertise, a well-functioning business environment and excellent logistics. For a technology trading group, the logistics and good international connections are a must. Both the harbors and the international airport are close-by in the Helsinki area.
